Literature DB >> 29996144

The Pentagon Copying Test and the Clock Drawing Test as Prognostic Markers in Dementia with Lewy Bodies.

Leonie J M Vergouw1, Mariet Salomé1,2, Anke G Kerklaan1, Christiaan Kies1, Gerwin Roks2, Esther van den Berg1, Frank Jan de Jong1.   

Abstract

AIMS: To determine whether the pentagon copying test (PCT) and the clock drawing test (CDT) are associated with nursing home admission or survival in dementia with Lewy bodies (DLB).
METHODS: The PCT and/or the CDT were retrospectively collected from 103 clinically diagnosed probable DLB patients at a university medical center and general hospital. Patients with high versus low scores on these tests were compared.
RESULTS: Kaplan-Meier analysis showed that patients with a low score on the PCT had a shorter time to nursing home admission than patients with a high score (log-rank χ2 = 6.1, p = 0.01). Patients with a low score on the PCT or the CDT had a shorter survival than patients with a high score (log-rank χ2 = 5.4, p = 0.02, and log-rank χ2 = 11.2, p < 0.001, respectively). Cox regression analyses showed the same associations with an HR of 2.2 (95% CI 1.2-4.1) for the PCT and an HR of 2.9 (95% CI 1.6-5.4) for the CDT.
CONCLUSION: The PCT and the CDT may function as prognostic markers in DLB. This finding is clinically relevant as these tests can be applied easily in the clinical setting and can provide valuable prognostic information. Furthermore, it may improve disease management and patient selection for research purposes. The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Clock drawing test; Dementia with Lewy bodies; Pentagon copying test; Prognostic marker

Mesh:

Year:  2018        PMID: 29996144      PMCID: PMC6159833          DOI: 10.1159/000490045

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  34 in total

1.  Predictors of survival in dementia with lewy bodies and Parkinson dementia.

Authors:  Kurt A Jellinger; Gregor K Wenning; Klaus Seppi
Journal:  Neurodegener Dis       Date:  2007-10-09       Impact factor: 2.977

2.  Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.

Authors:  Fredrik Boström; Oskar Hansson; Kaj Blennow; Lars Gerhardsson; Thomas Lundh; Lennart Minthon; Henrik Zetterberg; Elisabet Londos
Journal:  Dement Geriatr Cogn Disord       Date:  2009-10-21       Impact factor: 2.959

3.  Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Bradley F Boeve; Jonathan Graff-Radford; Walter A Rocca; Michelle M Mielke
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

4.  Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.

Authors:  David J Irwin; Murray Grossman; Daniel Weintraub; Howard I Hurtig; John E Duda; Sharon X Xie; Edward B Lee; Vivianna M Van Deerlin; Oscar L Lopez; Julia K Kofler; Peter T Nelson; Gregory A Jicha; Randy Woltjer; Joseph F Quinn; Jeffery Kaye; James B Leverenz; Debby Tsuang; Katelan Longfellow; Dora Yearout; Walter Kukull; C Dirk Keene; Thomas J Montine; Cyrus P Zabetian; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2017-01       Impact factor: 44.182

5.  Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

Authors:  P M Mattila; J O Rinne; H Helenius; D W Dickson; M Röyttä
Journal:  Acta Neuropathol       Date:  2000-09       Impact factor: 17.088

6.  Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease.

Authors:  Monique M Williams; Chengjie Xiong; John C Morris; James E Galvin
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

Review 7.  Survival in dementia and predictors of mortality: a review.

Authors:  Stephen Todd; Stephen Barr; Mark Roberts; A Peter Passmore
Journal:  Int J Geriatr Psychiatry       Date:  2013-03-22       Impact factor: 3.485

Review 8.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

9.  Executive deficits are related to the inferior frontal junction in early dementia.

Authors:  Matthias L Schroeter; Barbara Vogt; Stefan Frisch; Georg Becker; Henryk Barthel; Karsten Mueller; Arno Villringer; Osama Sabri
Journal:  Brain       Date:  2011-12-19       Impact factor: 13.501

Review 10.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

Authors:  C H Williams-Gray; T Foltynie; C E G Brayne; T W Robbins; R A Barker
Journal:  Brain       Date:  2007-05-29       Impact factor: 13.501

View more
  1 in total

1.  The gesture imitation test in dementia with Lewy bodies and Alzheimer's disease dementia.

Authors:  Xudong Li; Miaoxin Shen; Ziling Han; Jinsong Jiao; Xiaopeng Tong
Journal:  Front Neurol       Date:  2022-07-29       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.